This inventor holds 2 USPTO granted patents. Top assignees: Sloan-Kettering Institute for Cancer Research, University of Rochester. Active years: 1996-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 519 
2 out of 994 
Years Active: 1996-1997
Title: The Innovative Contributions of Krzystof W. Pankiewicz
Introduction
Krzystof W. Pankiewicz, based in Bronxville, NY, is an accomplished inventor with a remarkable record of innovation in the field of pharmaceuticals. With two patents to his name, he has developed important compounds that have potential implications in the treatment of various disorders.
Latest Patents
Pankiewicz's latest patents include significant advancements in pharmaceutical compositions. One patent titled "Analogues of adenosine 5' diphosphate and pharmaceutical compositions" presents a compound with a complex structure that provides potential treatments for NAD-dependent enzyme associated disorders. The invention details methods for preparing these compounds and emphasizes the versatility of the compound based on various chemical structures.
Another noteworthy patent is focused on "C-nucleoside isosters of analogs thereof and pharmaceutical compositions." This patent outlines a similar compound structure aimed at addressing the same class of disorders, further showcasing Pankiewicz’s contributions to medicinal chemistry and pharmaceutical innovation.
Career Highlights
Krzystof W. Pankiewicz has held significant positions at leading research institutions. He has worked at the Sloan-Kettering Institute for Cancer Research, where he contributed to groundbreaking cancer research initiatives. Additionally, his tenure at the University of Rochester added to his wealth of experience in academic research and innovation in the pharmaceutical field.
Collaborations
Throughout his career, Pankiewicz has collaborated with distinguished professionals, including Kyoichi A. Watanabe and Barry M. Goldstein. These partnerships have fostered an environment of innovation and contributed to the advancement of pharmaceutical research, further amplifying the impact of his inventions.
Conclusion
Krzystof W. Pankiewicz exemplifies the spirit of innovation within the pharmaceutical industry. His contributions through patents and collaborations with esteemed colleagues showcase his commitment to improving health outcomes. With a focus on addressing critical disorders, Pankiewicz continues to pave the way for future breakthroughs in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile